drug

Clonidine

clonidine
MeSH D003000
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Birte Glenthoj
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

2
Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia
NCT01598896Phase 2, Phase 3Terminated
Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia?
NCT00206986—Completed

KOLs & investigators

2
Birte Glenthoj, MD, DMSc.KOL score 5
Kevin P Hill, MD, MHS

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Birte Glenthoj
company
trial
Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia
PHASE2, PHASE3
trial
Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia?
NA
trial
indication
Schizophrenia
indication
Marijuana Abuse
indication
Marijuana Dependence
indication
Schizophrenia
indication
KOL
Birte Glenthoj, MD, DMSc.
KOL score 5
person
Kevin P Hill, MD, MHS
KOL score —
person